Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Structurally optimized potent dual-targeting NBTI antibacterials with an enhanced bifurcated halogen-bonding propensity
ID
Kokot, Maja
(
Author
),
ID
Weiss, Matjaž
(
Author
),
ID
Zdovc, Irena
(
Author
),
ID
Hrast, Martina
(
Author
),
ID
Anderluh, Marko
(
Author
),
ID
Minovski, Nikola
(
Author
)
PDF - Presentation file,
Download
(2,92 MB)
MD5: 51A524CEF864D7B1E316043F423040F5
URL - Source URL, Visit
https://pubs.acs.org/doi/10.1021/acsmedchemlett.1c00345
Image galllery
Abstract
We designed and synthesized an optimized library of novel bacterial topoisomerase inhibitors with p-halogenated phenyl right-hand side fragments and significantly enhanced and balanced dual-targeted DNA gyrase and topoisomerase IV activities of Staphylococcus aureus and Escherichia coli. By increasing the electron-withdrawing properties of the p-halogenated phenyl right-hand side fragment and maintaining a similar lipophilicity and size, an increased potency was achieved, indicating that the antibacterial activities of this series of novel bacterial topoisomerase inhibitors against all target enzymes are determined by halogen-bonding rather than van der Waals interactions. They show nanomolar enzyme inhibitory and whole-cell antibacterial activities against S. aureus and methicillin-resistant S. aureus (MRSA) strains. However, due to the relatively high substrate specificity for the bacterial efflux pumps, they tend to be less potent against E. coli and other Gram-negative pathogens.
Language:
English
Keywords:
NBTIs
,
DNA gyrase
,
topoisomerase IV
,
bifurcated halogen bonds
,
dual targeting
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2021
Number of pages:
Str. 1478-1485
Numbering:
Vol. 12, iss. 9
PID:
20.500.12556/RUL-141453
UDC:
615.4:54:579
ISSN on article:
1948-5875
DOI:
10.1021/acsmedchemlett.1c00345
COBISS.SI-ID:
73185027
Publication date in RUL:
29.09.2022
Views:
657
Downloads:
66
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
ACS medicinal chemistry letters
Publisher:
American Chemical Society
ISSN:
1948-5875
COBISS.SI-ID:
2959217
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0017-2020
Name:
Modeliranje kemijskih procesov in lastnosti spojin
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208-2022
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
Other - Other funder or multiple funders
Funding programme:
Young Researcher’s Program
Project number:
39010
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back